I Soft Ophthalmic Solution

Introduction

I Soft is a prescription medication that contains Sodium Hyaluronate as its active ingredient. It is available in the form of an eye drop solution. This medication is primarily used for the treatment of certain eye conditions that result in dryness and discomfort.

Uses

I Soft is prescribed for individuals who experience dryness and irritation in the eyes. It is commonly used in cases of dry eye syndrome, a condition that occurs when the eyes do not produce enough tears or when the tears evaporate too quickly. This medication helps to lubricate and moisturize the eyes, providing relief from symptoms such as itching, burning, and redness.

Dosage and Administration

The recommended dosage of I Soft may vary depending on the severity of the condition and the individual patient. Follow the instructions provided by your healthcare professional. In general, the usual dosage is one to two drops in each affected eye, administered two to four times daily. Wash your hands before using the eye drops and to avoid touching the tip of the dropper to prevent contamination.

Mechanism of Action

Sodium Hyaluronate, the active ingredient in I Soft, works by forming a protective and moisturizing layer on the surface of the eye. It helps to retain moisture and lubricate the eyes, reducing dryness and discomfort. This medication also promotes the natural healing process of the eye, providing further relief from symptoms.

Side Effects

Common side effects may include temporary stinging or burning sensation in the eyes after application. These effects are usually mild and transient. If you experience any persistent or severe side effects, such as eye pain, vision changes, or signs of an allergic reaction (e.g., rash, itching, swelling), seek medical attention promptly.

Drug Interactions

There are currently no known drug interactions with I Soft. However, it is always important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to ensure there are no potential interactions.

Precautions

Before using I Soft, inform your healthcare professional if you have any known allergies or sensitivities to Sodium Hyaluronate or any other ingredients in the medication. Disclose any other eye conditions or ongoing treatments to ensure the safe use of this medication.

Storage

I Soft should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep the bottle tightly closed when not in use. Check the expiration date on the packaging and discard any expired medication. Do not freeze the solution.

Patient Tips

• Wash your hands before using the eye drops to prevent contamination.
• Tilt your head back slightly and pull down the lower eyelid to create a small pocket. Squeeze the prescribed number of drops into the pocket, avoiding contact between the dropper and your eye or eyelid.
• Close your eyes gently after applying the drops to aid in distribution.
• If you are using other eye medications, wait at least 5 minutes between applying each medication to prevent interactions.
• If your symptoms persist or worsen despite using I Soft, consult your healthcare professional for further evaluation and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Vitamins and minerals – Others (NHS UK) [Accessed 11 Jun. 2024] (online) Available at:
• Sodium hyaluronate injection (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
• sodium hyaluronate 10 mg/ml intra-articular solution (RX) [Accessed 26 Jun. 2024] (online) Available at:
• Medicines, injections, and supplements for arthritis (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW; Cosmetic Ingredient Review Expert Panel; Andersen FA. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009 Jul-Aug;28(4 Suppl):5-67. doi: 10.1177/1091581809337738. [Accessed 28 Jun. 2024] Available at: